Because at least for EPP, they have market exclusivity for many years post approval for following an orphan disease indication. They also have patents over the slow release delivery method for the drug.
- Forums
- ASX - By Stock
- BOOM ! Bio-tech giant in the making
Because at least for EPP, they have market exclusivity for many...
Featured News
Add CUV (ASX) to my watchlist
|
|||||
Last
$14.19 |
Change
0.030(0.21%) |
Mkt cap ! $707.5M |
Open | High | Low | Value | Volume |
$14.20 | $14.24 | $14.10 | $237.1K | 16.71K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 141 | $14.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.19 | 131 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 122 | 14.210 |
4 | 415 | 14.200 |
2 | 92 | 14.190 |
1 | 48 | 14.180 |
1 | 48 | 14.170 |
Price($) | Vol. | No. |
---|---|---|
14.240 | 109 | 5 |
14.250 | 846 | 4 |
14.260 | 45 | 1 |
14.270 | 49 | 1 |
14.290 | 48 | 1 |
Last trade - 11.05am 15/08/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online